3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Polycythemia Vera
2
Myeloproliferative Disorders
2
Lung Neoplasms
2
Tuberous Sclerosis
1
Smoking
1
Renal Insufficiency, Chronic
1
Pancreatitis, Chronic
1
Pancreatitis
1
Pancreatic Cyst
1
Non-alcoholic Fatty Liver Disease
1
Neoplasms
1
Multiple Sclerosis
1
Lymphangioleiomyomatosis
1
Liver Cirrhosis, Biliary
1
Lip Neoplasms
1
Irritable Bowel Syndrome
1
Inflammatory Bowel Diseases
1
Hepatitis
1
Head and Neck Neoplasms
1
Genetic Predisposition to Disease
1
Gastritis
1
Fibrosis
1
Exocrine Pancreatic Insufficiency
1
Endocrine Gland Neoplasms
1
Dyslipidemias
1
Diabetes Mellitus
1
Cystic Fibrosis
1
Crohn Disease
1
Chronic Pain
1
Chronic Disease
1
Interventions
lutetium Lu 177 dotatate
20
Magnetic Resonance Spectroscopy
10
pembrolizumab
9
Specimen Handling
7
Everolimus
7
cabozantinib
6
Nivolumab
6
lenvatinib
5
177Lu-octreotide, DOTA(0)-Tyr(3)-
5
surufatinib
4
amino-acid, glucose, and electrolyte solution
4
Capecitabine
4
olaparib
3
lanreotide
3
atezolizumab
3
Temozolomide
3
Octreotide
3
Lutetium-177
3
Ipilimumab
3
Injections
3
Fluorodeoxyglucose F18
3
Cyclophosphamide
3
gallium Ga 68 dotatate
2
fludarabine phosphate
2
fludarabine
2
avelumab
2
X-Rays
2
Radiotherapy
2
Phantoms, Imaging
2
PM 01183
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroendocrine Tumors
×
Phlebotomy
×
1 year
×
Clear all
No trials found.